Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
binding, Carboplatin, contemplated, enable, FIH, hydrogel, imposed, Patil, reinstating, restore, root, Sanguansak, surgical, Thuss, Uttam, window, Xinnovation
Removed:
abandoned, acquirer, adequate, autoimmunity, averaged, cancelled, Concept, confirmed, consolidation, consummation, conveyance, demonstrating, earliest, endpoint, EPS, evidencing, exempt, explore, fractionalized, gave, half, historically, Hong, improved, inflammation, involving, Kong, Maitake, mushroom, nonrecurring, offshore, Parent, placebo, POC, Proof, proposed, pursuing, recapitalization, recast, reflected, released, represented, resume, Scale, showed, signal, significantly, stream, stronger, surrender, thereunder, translational, treasury, virtue, wholly
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view